Literature DB >> 28714326

Spinal cord ischemia-reperfusion causes damage of neurocyte by inhibiting RAP2C.

Yong Qiao1, Changliang Peng1, Ji Li1, Dongjin Wu1, Xiuwen Wang1.   

Abstract

OBJECTIVE: To explore the mechanism of RAP2C participating in spinal cord ischemia-reperfusion injury (SCII).
MATERIALS AND METHODS: mRNA expressions of miR-204 and RAP2C were measured by qRT-PCR. Protein level of RAP2C was detected by Western blot. Cell apoptosis in AGE1.HN and PC12 cells was detected by Annexin V/propidium iodide assay. The effect of miR-204 knockdown or overexpression on RAP2C expression was observed by luciferase assay.
RESULTS: In this experimental research, RAP2C expression in SCII group was lower than control group, while miR-204 expression was higher. In addition, RAP2C expression in AGE1.HN and PC12 cells under hypoxic condition was lower than control group, while miR-204 expression was higher. Hypoxia increased cell apoptosis, and overexpression of RAP2C reversed this effect. In cells treated with hypoxia and miRNA-204 inhibitor, hypoxia upregulated the expression of miR-204, while miRNA-204 inhibitor reversed this effect. Hypoxia downregulated the expression of RAP2C, while miR-204 inhibitor reversed this effect. Moreover, miR-204 could bind to 3'-UTR of RAP2C. And miR-204 inhibitor upregulated the activity and expression of RAP2C, while miR-204 mimic played the opposite role. Finally, hypoxia downregulated RAP2C expression, miR-204 inhibitor upregulated RAP2C expression, while Ad-sh-RAP2C inhibited RAP2C expression. What's more, hypoxia increased the apoptosis rate, miR-204 inhibitor decreased the apoptosis rate, while si-RAP2C increased the apoptosis rate.
CONCLUSION: SCII causes increase of neurocyte apoptosis by inhibiting RAP2C via miR-204.

Entities:  

Keywords:  RAP2C; Spinal cord ischemia-reperfusion injury (SCII); apoptosis; miR-204

Mesh:

Substances:

Year:  2017        PMID: 28714326     DOI: 10.1080/01616412.2017.1352120

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  5 in total

Review 1.  The roles of microRNAs in spinal cord ischemia-reperfusion injury.

Authors:  Feng-Shou Chen; Xiang-Yi Tong; Bo Fang; Dan Wang; Xiao-Qian Li; Zai-Li Zhang
Journal:  Neural Regen Res       Date:  2022-12       Impact factor: 6.058

2.  Methotrexate remediates spinal cord injury in vivo and in vitro via suppression of endoplasmic reticulum stress-induced apoptosis.

Authors:  Fengju Rong; Xue Gao; Kexin Liu; Jintao Wu
Journal:  Exp Ther Med       Date:  2018-03-20       Impact factor: 2.447

3.  MicroRNA-204 may participate in the pathogenesis of hypoxic-ischemic encephalopathy through targeting KLLN.

Authors:  Ronglin Chen; Meixia Wang; Shaopin Fu; Feng Cao; Pengkai Duan; Jiefu Lu
Journal:  Exp Ther Med       Date:  2019-08-26       Impact factor: 2.447

4.  MicroRNA‑200c‑3p suppresses intervertebral disc degeneration by targeting RAP2C/ERK signaling.

Authors:  Jianping Cao; Meng Jiang; Huafeng Ren; Kai Xu
Journal:  Mol Med Rep       Date:  2021-10-22       Impact factor: 2.952

5.  Quantitative proteomics reveal the alterations in the spinal cord after myocardial ischemia‑reperfusion injury in rats.

Authors:  Shun-Yuan Li; Zhi-Xiao Li; Zhi-Gang He; Qian Wang; Yu-Juan Li; Qing Yang; Duo-Zhi Wu; Hao-Long Zeng; Hong-Bing Xiang
Journal:  Int J Mol Med       Date:  2019-09-17       Impact factor: 4.101

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.